20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
This episode dissects the venture capital landscape through the lens of recent mega-deals and market concentration, examining how Andreessen Horowitz has captured two-thirds of private AI revenue and what this means for the asset class. The discussion tackles the uncomfortable realities of 2021's high valuations, the economics of late-stage investing, and whether venture capital is finally maturing into a predictable asset class dominated by a few winners.
Key takeaways
- •Andreessen Horowitz controls two-thirds of private AI revenue through portfolio companies like OpenAI, Databricks, and Cursor, suggesting unprecedented market concentration.
- •Late-stage investors can absorb 40% one-x returns as long as their winners deliver 3-6x multiples, making high valuations a calculated cost of doing business.
- •Venture capital may finally qualify as a true asset class if top-tier firms like a16z can repeatably capture market penetration while platforms like YC dominate early-stage deal flow.
- •AI inference costs will continue rising despite falling per-token prices because demand expansion drives higher total token usage across the knowledge worker population.
- •Taking money at peak valuations creates temporary discomfort during down rounds, but rational founders should never refuse higher prices when offered by investors.
Two episodes. Free. Clips before your next meeting.
No card. No setup call. Paste your episode and see what Clypt surfaces.